Financials

News Discussions Technicals Seasonals

WFL fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

‪1.48 M‬AUD

—

—

—

1992

—

—

—

About

Wellfully Ltd. is a science-based wellness company, which engages in the research and development of dermaportation and enhance transdermal polymer technologies. It operates through the Dermaportation and Drug Delivery Technology and Devices segments. The company was founded by Jeffery David Edwards in June 22, 1992 and is headquartered in Perth, Australia.

Ownership

‪‪492.94 M‬‬

Free Float shares

‪‪491.05 M‬‬ (99.62%)

Closely held shares

‪‪1.89 M‬‬ (0.38%)

Free Float shares

‪‪491.05 M‬‬ (99.62%)

Closely held shares

‪‪1.89 M‬‬ (0.38%)

Capital structure

No data available

There's currently no data to show about this capital structure.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

‪‪1.48 M‬‬

Price to earning ratio (P/E)

—

Price to sales ratio (P/S)

—

Market Cap

Net income

Revenue

Price to earning ratio (P/E)

—

Price to sales ratio (P/S)

—

Valuation ratios

H2 '22

H1 '23

H2 '23

H1 '24

H2 '24

‪0.00‬

‪1.70‬

‪3.40‬

‪5.10‬

‪6.80‬

P/S

Growth and Profitability

Company’s recent performance and margins

Performance

‪−1,800.0%‬

‪−1,200.0%‬

‪−600.0%‬

‪0.0%‬

‪600.0%‬

H2 '22

H1 '23

H2 '23

H1 '24

‪‪−5.10 M‬‬

‪‪−3.40 M‬‬

‪‪−1.70 M‬‬

‪0.00‬

‪‪1.70 M‬‬

Revenue

Net income

Net margin %

Revenue to profit conversion

No data available

There's currently no revenue data to show for the selected period.

Dividends

Dividend yield, history and sustainability

WFL does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage

H2 '22

H1 '23

H2 '23

H1 '24

H2 '24

‪‪−4.50 M‬‬

‪‪−3.00 M‬‬

‪‪−1.50 M‬‬

‪0.00‬

‪‪1.50 M‬‬

Debt

Free cash flow

Cash & equivalents

Financial position analysis

No data available

There's currently no assets and liabilities data to show.